Cationic lipids for use in lipid nanoparticles
NZ835066APending Publication Date: 2026-07-31ACUITAS THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- NZ835066
- Authority / Receiving Office
- NZ · NZ
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-05-14
- Filing Date
- 2021-07-16
- Publication Date
- 2026-07-31
Smart Images
Figure 1_ABST
Abstract
Compounds are provided having the following structure:, (I) or a pharmaceutically acceptable salt, tautomer, or stereoisomer thereof, wherein a, b, c, d, G1, G2, L1, L2, R1a, R1b, R2a, R2b, R3a, R3b, R4a, R4b, R5, R6, R7, R8 and X are as defined herein. Use of the compounds as a component of lipid nanoparticle formulations for delivery of a therapeutic agent, nanoparticles comprising the compounds and methods for their use and preparation are also provided.
Need to check novelty before this filing date? Find Prior Art